Ocular oncology: diagnosis and management of malignant intraocular tumors

References

• Shields JA, Shields CL. Intraocular Tumors: A Text and Atlas. Saunders, PA, USA, 119–205 (1992).
   Google Scholar
• *Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology110, 956–961 (2003).
   PubMed Web of Science ®Google Scholar
• Gündüz K, Shields JA, Shields CL, Eagle RC Jr. Choroidal melanoma in a 14-year-old patient with ocular melanocytosis. Arch. Ophthalmol.116, 1112–1114 (1998).
   PubMedGoogle Scholar
• Egan KM, Seddon JM, Glynn RJ et al. Epidemiologic aspects of uveal melanoma. Surv. Ophthalmol.32, 239–251 (1988).
   PubMed Web of Science ®Google Scholar
• Margo CE, Mulla Z, Billiris K. Incidence of surgically treated uveal melanoma by race and ethnicity. Ophthalmology105, 1087–1090 (1998).
   PubMed Web of Science ®Google Scholar
• Char DH. Clinical Ocular Oncology (2nd Ed). Lipponcott-Raven, PA, USA 89–191 (1997).
   Google Scholar
• Singh AD, DePotter P, Fijal BA et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology105, 195–198 (1998).
   PubMed Web of Science ®Google Scholar
• Albert DM, Chang MA, Lamping K et al. The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroids and skin. Ophthalmology92, 1728–1734 (1985).
   PubMed Web of Science ®Google Scholar
• Wiznia RA, Freedman JK, Mancini AD et al. Malignant melanoma of the choroids in neurofibromatosis. Am. J. Ophthalmol.86, 684–687 (1978).
   PubMed Web of Science ®Google Scholar
• Speicher MR, Prescher G, du Manoir S et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res.54, 3817–3823 (1994).
   PubMed Web of Science ®Google Scholar
• Prescher G, Bornfeld N, Hirche H et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet347, 1222–1225 (1996).
   PubMed Web of Science ®Google Scholar
• Lois N, Shields CL, Shields JA et al. Trifocal uveal melanoma. Am. J. Ophthalmol.124, 848–850 (1997).
   PubMedGoogle Scholar
• Singh AD, Shields CL, DePotter P et al. Familial uveal melanoma. Clinical observations on 56 patients. Arch. Ophthalmol.114, 392–399 (1996).
   PubMedGoogle Scholar
• Travis LB, Curtis RE, Boice JD Jr et al. Second malignant neoplasms among long term survivors of ovarian cancer. Cancer Res.56, 1564–1570 (1996).
   PubMed Web of Science ®Google Scholar
• Wooster R, Neuhausen S, Mangion J et al. Localisation of a breast cancer susceptibility gene to chromosome 13q12–q13. Science265, 2088–2090 (1994).
   PubMed Web of Science ®Google Scholar
• *Shields CL, Cater J, Shields JA et al. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch. Ophthalmol.118, 360–364 (2000).
   PubMedGoogle Scholar
• Abramson DH, Servodidio CA, McCormick B et al. Changes in height of choroidal melanomas after plaque therapy. Br. J. Ophthalmol.74, 359–362 (1990).
   PubMedGoogle Scholar
• Damato BE. Tumour fluorescence and tumor-associated fluorescence of choroidal melanomas. Eye6, 587–593 (1992).
   PubMedGoogle Scholar
• Scott IU, Murray TG, Hughes JR. Evaluation of imaging techniques for detection of extraocular extension of choroidal melanoma. Arch. Ophthalmol.116, 897–899 (1998).
   PubMedGoogle Scholar
• Shields JA, Shields CL, Ehya H et al. Fine-needle aspiration biopsy of suspected intraocular tumors. The (1992) Urwick Lecture. Ophthalmology100, 1677–1684 (1993).
   PubMed Web of Science ®Google Scholar
• Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS Report no. 15. Arch. Ophthalmol.119, 670–676 (2001).
   PubMedGoogle Scholar
• McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender’s classification of uveal melanoma at the Armed Forces Institute of Pathology. Am. J. Ophthalmol.96, 502–509 (1983).
   PubMed Web of Science ®Google Scholar
• Rummelt V, Folberg R, Woolson RF et al. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology102, 844–851 (1995).
   PubMedGoogle Scholar
• Eide N. Primary laser photocoagulation of “small” choroidal melanomas. Acta Ophthalmol. Scand.77, 351–354 (1999).
   PubMedGoogle Scholar
• Bartlema YM, Oosterhius JA, Journee-De Korver JG et al. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years’ experience. Br. J. Ophthalmol.87, 1370–1373 (2003).
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Perez N et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases. Ophthalmology109, 225–234 (2002).
   PubMed Web of Science ®Google Scholar
• Gündüz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch. Ophthalmol.117, 170–177 (1999).
   PubMedGoogle Scholar
• Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch. Clin. Exp. Ophthalmol.238(2), 129–137 (2000).
   PubMed Web of Science ®Google Scholar
• Augsburger JJ, Gamel JW, Shields JA et al. Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease. Ophthalmology94, 1173–1177 (1987).
   PubMed Web of Science ®Google Scholar
• Gündüz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch. Ophthalmol.117, 609–614 (1999).
   PubMedGoogle Scholar
• Gündüz K, Shields CL, Shields JA, Cater J, Brady L. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am. J. Ophthalmol.130, 97–102 (2000).
   PubMed Web of Science ®Google Scholar
• Char DH, Kroll SM, Castro J. Ten year follow-up of helium ion therapy for uveal melanoma. Am. J. Ophthalmol.125, 81–89 (1998).
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Seddon JM, Egan K et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology94, 349–353 (1987).
   PubMed Web of Science ®Google Scholar
• Dieckmann K, Georg D, Zehetmayer M et al. LINAC based stereotactic radiotherapy of uveal melanoma: 4 years of clinical experience. Radiother. Oncol.67, 199–206 (2003).
   PubMed Web of Science ®Google Scholar
• Mueller AJ, Talies S, Schaller UC et al. Stereotactic radiosurgery of large uveal melanomas with the gamma knife. Ophthalmology107, 1381–1387 (2000).
   PubMed Web of Science ®Google Scholar
• Shields JA, Shields CL, Shah P, Sivalingham V. Partial lamellar sclerouvectomy for ciliary body and choroidal tumors. Ophthalmology98, 971–983 (1991).
   PubMedGoogle Scholar
• Damato B, Groenewald C, McGalliard J, Wong D. Endoresection of choroidal melanoma. Br. J. Ophthalmol.82, 213–218 (1998).
   PubMed Web of Science ®Google Scholar
• Bechrakis NE, Hocht S, Martus P et al. Endoresection following proton-beam irradiation of large uveal melanomas. Ophthalmologe101, 370–376 (2004).
   PubMedGoogle Scholar
• Damato B, Wong D, Green FD, Mackenzie JM. Intrascleral recurrence of uveal melanoma after transretinal ‘endoresection’. Br. J. Ophthalmol.85, 114–115 (2001).
   PubMed Web of Science ®Google Scholar
• Ashworth JL, Rhatigan M, Sampath R et al. The hydroxyapatite orbital implant: a prospective study. Eye10, 29–37 (1996).
   PubMed Web of Science ®Google Scholar
• Kersten RC, Tse DT, Anderson RL, Blodi FC. The role of orbital exenteration in choroidal melanoma with extrascleral extension. Ophthalmology92, 436–443 (1985).
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial of a rare condition. Collaborative Clin. Trials14, 362–391 (1993).
   Google Scholar
• The Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma: COMS Report no 5. Arch. Ophthalmol.115, 1537–1544 (1997).
   PubMedGoogle Scholar
• The Collaborative Ocular Melanoma Study Group (COMS) randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report no.18. Arch. Ophthalmol.119, 969–982 (2001).
   PubMedGoogle Scholar
• The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am. J. Ophthalmol.125, 779–796 (1998).
   PubMed Web of Science ®Google Scholar
• Demirci H, Shields CL, Shields JA, Honavar SG, Eagle RC Jr. Ring melanoma of the ciliary body: report on twenty-three patients. Retina22, 698–706 (2002).
   PubMed Web of Science ®Google Scholar
• McLean IW, Ainbinder DJ, Gamel JW, McCurdy JB. Choroidal-ciliary body melanoma. A multivariate survival analysis to tumor location. Ophthalmology102, 1060–1064 (1995).
   PubMed Web of Science ®Google Scholar
• Foss AJ, Pecorella I, Alexander RA et al. Are most intraocular “leiomyomas” really melanocytic lesions? Ophthalmology101, 19–24 (1994).
   Google Scholar
• *Shields CL, Naseripour M, Shields JA, Freire J, Cater J. Custom-designed plaque radiotherapy for nonresectable iris melanomas in 38 patients: tumor control and ocular complications. Am. J. Ophthalmol.135, 648–656 (2003).
   PubMed Web of Science ®Google Scholar
• Demirci H, Shields CL, Shields JA et al. Diffuse iris melanoma: a report of 25 cases. Ophthalmology109, 1553–1560 (2002).
   PubMed Web of Science ®Google Scholar
• Bedikian AY, Legha SS, Mavligit G et al. Treatment of uveal melanoma metastatic to the liver: a review of MD Anderson Cancer Center experience and prognostic factors. Cancer76, 1665–1670 (1995).
   PubMed Web of Science ®Google Scholar
• Gündüz K, Shields JA, Shields CL et al. Surgical removal of solitary hepatic metastasis from choroidal melanoma. Am. J. Ophthalmol.125, 407–409 (1998).
   PubMedGoogle Scholar
• Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch. Ophthalmol.110, 245–250 (1992).
   PubMed Web of Science ®Google Scholar
• Fine SL, Straatsma BR, Earle JD, Hawkins BS, McLaughlin JA. Failure of preenucleation radiation to decrease uveal melanoma mortality. The Collaborative Ocular Melanoma Study Steering Committee. Am. J. Ophthalmol.107, 440–442 (1989).
   PubMedGoogle Scholar
• Diener-West M, Earle JD, Fine SL et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report no. 18. Arch. Ophthalmol.119, 969–982 (2001).
   PubMedGoogle Scholar
• Straatsma BR, Fine SL, Earle JD, Hawkins BS, Diener-West M, McLaughlin JA. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology95, 1000–1004 (1988).
   PubMed Web of Science ®Google Scholar
• Augsburger JJ, Gamel JW, Sardi VF, Greenberg RA, Shields JA, Brady LW. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch. Ophthalmol.104, 655–661 (1986).
   PubMedGoogle Scholar
• Chana JS, Wilson GD, Cree IA et al. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br. J. Ophthalmol.83, 110–114 (1999).
   PubMed Web of Science ®Google Scholar
• Anastassiou G, Tschentscher F, Zeschnigk M et al. Cadherin expression in uveal melanoma. Exp. Eye Res.74, 423–425 (2002).
   PubMedGoogle Scholar
• Brantley MA Jr, Harbour JW. Deregulation of the Rb and p53 pathways in uveal melanoma. Am. J. Pathol.57, 1795–1701 (2000).
   Google Scholar
• Ehlers JP, Worley L, Onken MD et al. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin. Cancer Res.11, 3609–3613 (2005).
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Harbour JW. NBS1 expression as a prognostic marker in uveal melanoma. Clin. Cancer Res.11, 1849–1853 (2005).
   PubMedGoogle Scholar
• Tschentscher F, Husing J, Holter T et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res.63, 2578–2584 (2003).
   PubMed Web of Science ®Google Scholar
• *Onken MD, Worley LA, Ehlers JP et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res.64, 7205–7209 (2004).
   PubMed Web of Science ®Google Scholar
• Tschentscher F, Prescher G, Zeschnigk M et al. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet. Cytogenet.122, 13–17 (2000).
   PubMedGoogle Scholar
• Loercher AE, Harbour JW. Molecular genetics of uveal melanoma. Curr. Eye Res.27, 69–74 (2003).
   PubMed Web of Science ®Google Scholar
• Tschentscher F, Prescher G, Horsman DE et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res.61, 3439–3442 (2001).
   PubMed Web of Science ®Google Scholar
• Prendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch. Ophthalmol.98, 1204–1210 (1980).
   PubMedGoogle Scholar
• Harbour JW. Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening. Ophthalmology105, 1442–1447 (1998).
   PubMed Web of Science ®Google Scholar
• Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br. J. Cancer66, 211–219 (1992).
   PubMedGoogle Scholar
• Singh AD, Santos CM, Shields CL et al. Observations on 17 patients with retinocytoma. Arch. Ophthalmol.118, 199–205 (2000).
   PubMedGoogle Scholar
• Shields JA, Parsons HM, Shields CL, Shah P. Lesions simulating retinoblastoma. J. Pediatr. Ophthalmol. Strabismus28, 338–340 (1991).
   PubMed Web of Science ®Google Scholar
• Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma. A possible age effect on radiation-related risk. Ophthalmology105, 573–579 (1998).
   PubMed Web of Science ®Google Scholar
• Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J. Clin. Oncol.17, 1829–1837 (1999).
   PubMed Web of Science ®Google Scholar
• Shields CL, Mashayekhi A, Au AK et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology (Epub ahead of print) (2006).
   Google Scholar
• Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol. Clin. North Am.18, 41–53 (2005).
   PubMedGoogle Scholar
• Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J. Pediatr. Ophthalmol. Strabismus36, 8–18 (1999).
   PubMedGoogle Scholar
• Toma NMG, Hungerford JL, Plowman PN et al. External beam radiotherapy for retinoblastoma: II. Lens sparing technique. Br. J. Ophthalmol.79, 112–117 (1995).
   PubMed Web of Science ®Google Scholar
• Murphree AL, Villablanca JG, Deegan WF et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch. Ophthalmol.114, 1348–1356 (1996).
   PubMed Web of Science ®Google Scholar
• Gallie BL, Budning A, De Boer G et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch. Ophthalmol.114, 1321–1328 (1996).
   PubMed Web of Science ®Google Scholar
• Wilson MW, Rodriguez-Galindo C, Haik BG et al. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology108, 2114–2115 (2001).
   Google Scholar
• Abramson DH, Frank CM, Dunkel IJ. A Phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology106, 1947–1950 (1999).
   PubMed Web of Science ®Google Scholar
• Abramson DH, Schefler AC. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology111, 984–991 (2004).
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Cater J et al. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology108, 2116–2121 (2001).
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Kiratli H, DePotter P. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J. Pediatr. Ophthalmol. Strabismus32, 317–322 (1995).
   PubMed Web of Science ®Google Scholar
• Jockovich ME, Murray TG, Escalona-Benz E et al. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice. Invest. Ophthalmol. Vis. Sci.47, 1264–1268 (2006).
   PubMed Web of Science ®Google Scholar
• Honavar SG, Shields CL, Shields JA et al. Intraocular surgery after treatment of retinoblastoma. Arch. Ophthalmol.119, 1613–1621 (2001).
   PubMedGoogle Scholar
• Rodriguez-Galindo C, Wilson MW, Haik BG et al. Treatment of metastatic retinoblastoma. Ophthalmology110, 1237–1240 (2003).
   PubMed Web of Science ®Google Scholar
• Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol. Clin. North Am.18, 65–73 (2005).
   PubMedGoogle Scholar
• Gündüz K, Müftüoğlu O, Günalp I et al. Metastatic retinoblastoma: Clinical features, treatment, and prognosis. Ophthalmology113, 1558–1566 (2006).
   PubMed Web of Science ®Google Scholar
• Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv. Ophthalmol.47, 1–16 (2002).
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastasis. Ophthalmology104, 1265–1276 (1997).
   PubMed Web of Science ®Google Scholar
• Gündüz K, Shields JA, Shields CL et al. Ewing sarcoma metastatic to the iris. Am. J. Ophthalmol.124, 550–552 (1997).
   PubMedGoogle Scholar
• Shields JA, Shields CL, Singh AD. Metastatic neoplasms in the optic disc: the 1999 Bjerrum Lecture: part II. Arch. Ophthalmol.118, 217–224 (2000).
   PubMedGoogle Scholar
• Gündüz K, Shields JA, Shields CL et al. Lung carcinoma metastatic to the vitreous cavity. Retina18, 285–286 (1998).
   PubMedGoogle Scholar
• Shields JA, Shields CL, Gündüz K, Eagle RC Jr. Neoplasms of the retinal pigment epithelium. The 1998 Albert Ruedemann Sr Memorial Lecture, Part 2. Arch. Ophthalmol.117, 601–608 (1999).
   PubMedGoogle Scholar
• Singh AD, Rundle PA, Longstaff S et al. Iris pigment epithelial adenoma: resection and repair. Eye20, 385–386 (2006).
   PubMedGoogle Scholar
• Dinakaran S, Rundle PA, Parsons MA, Rennie IG. Adenoma of ciliary pigment epithelium: a case series. Br. J. Ophthalmol.87, 504–505 (2003).
   PubMedGoogle Scholar
• Suzuki J, Goto H, Usui M. Adenoma arising from nonpigmented ciliary epithelium concomitant with neovascularization of the optic disc and cystoid macular edema. Am. J. Ophthalmol.139, 188–190 (2005).
   PubMed Web of Science ®Google Scholar
• Broughton WL, Zimmerman LE. A clinicopathologic study of 56 cases of intraocular medulloepitheliomas. Am. J. Ophthalmol.85, 407–418 (1978).
   PubMed Web of Science ®Google Scholar
• Shields JA, Eagle RC Jr, Shields CL, DePotter P. Congenital neoplasms of the nonpigmented ciliary epithelium (medulloepithelioma). Ophthalmology103, 1998–2006 (1996).
   PubMedGoogle Scholar
• Zaldivar RA, Martin DF, Holden JT et al. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology111, 1762–1767 (2004).
   PubMed Web of Science ®Google Scholar
• Chan CC, Shen DF, Whitcup SM, Nussenblatt RB. Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphoma. Blood93, 2749–2751 (1999).
   PubMed Web of Science ®Google Scholar
• Buggage RR, Whitcup SM, Nussenblatt CC. Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis. Invest. Ophthalmol. Vis. Sci.40, 2462–2463 (1999).
   PubMed Web of Science ®Google Scholar
• Pavan PR, Oteiza EE, Margo CE. Ocular lymphoma diagnosed by subretinal pigment epithelium biopsy. Arch. Ophthalmol.113, 1233–1234 (1995).
   PubMedGoogle Scholar
• Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr. Opin. Ophthalmol.13, 411–418 (2002).
   PubMedGoogle Scholar
• Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol. Oncol. Clin. North Am.19, 739–749 (2005).
   PubMed Web of Science ®Google Scholar
• Smith JR, Rosenbaum JT, Wilson DJ et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology109, 1709–1716 (2002).
   PubMed Web of Science ®Google Scholar